A detailed history of Louisiana State Employees Retirement System transactions in Myriad Genetics Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 43,800 shares of MYGN stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
43,800
Previous 44,400 1.35%
Holding current value
$1.14 Million
Previous $849,000 9.89%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$17.59 - $23.59 $10,554 - $14,154
-600 Reduced 1.35%
43,800 $933,000
Q4 2023

Jan 29, 2024

BUY
$13.91 - $21.32 $37,557 - $57,564
2,700 Added 6.47%
44,400 $849,000
Q3 2023

Oct 17, 2023

SELL
$15.99 - $23.22 $17,589 - $25,542
-1,100 Reduced 2.57%
41,700 $668,000
Q2 2023

Jul 18, 2023

BUY
$17.56 - $23.76 $87,800 - $118,800
5,000 Added 13.23%
42,800 $992,000
Q1 2023

Apr 19, 2023

SELL
$15.26 - $23.75 $10,682 - $16,625
-700 Reduced 1.82%
37,800 $878,000
Q3 2022

Oct 19, 2022

SELL
$18.21 - $27.88 $5,463 - $8,364
-300 Reduced 0.77%
38,500 $735,000
Q1 2022

Apr 22, 2022

BUY
$22.67 - $28.01 $2,267 - $2,801
100 Added 0.26%
38,800 $891,000
Q4 2021

Jan 14, 2022

BUY
$24.13 - $32.63 $26,543 - $35,893
1,100 Added 2.93%
38,700 $1.07 Million
Q3 2021

Oct 12, 2021

BUY
$29.97 - $36.66 $86,913 - $106,313
2,900 Added 8.36%
37,600 $1.21 Million
Q2 2021

Jul 16, 2021

BUY
$25.39 - $32.61 $12,695 - $16,305
500 Added 1.46%
34,700 $1.06 Million
Q1 2021

Apr 14, 2021

SELL
$19.92 - $31.6 $7,968 - $12,640
-400 Reduced 1.16%
34,200 $1.04 Million
Q3 2020

Oct 19, 2020

BUY
$11.25 - $14.75 $161,212 - $211,367
14,330 Added 70.7%
34,600 $451,000
Q2 2020

Jul 13, 2020

SELL
$10.69 - $16.49 $3,207 - $4,946
-300 Reduced 1.46%
20,270 $230,000
Q1 2020

Apr 13, 2020

SELL
$9.78 - $29.53 $48,313 - $145,878
-4,940 Reduced 19.36%
20,570 $294,000
Q4 2019

Jan 17, 2020

SELL
$20.93 - $35.1 $37,464 - $62,829
-1,790 Reduced 6.56%
25,510 $695,000
Q3 2019

Oct 24, 2019

SELL
$22.08 - $47.08 $2,208 - $4,708
-100 Reduced 0.36%
27,300 $782,000
Q1 2019

Apr 15, 2019

SELL
$26.93 - $34.7 $18,231 - $23,491
-677 Reduced 2.41%
27,400 $910,000
Q4 2018

Jan 14, 2019

SELL
$27.23 - $45.56 $87,762 - $146,839
-3,223 Reduced 10.3%
28,077 $816,000
Q2 2018

Jul 18, 2018

BUY
$27.75 - $40.17 $8,325 - $12,051
300 Added 0.97%
31,300 $1.17 Million
Q1 2018

Apr 18, 2018

BUY
$28.83 - $41.01 $34,596 - $49,212
1,200 Added 4.03%
31,000 $916,000
Q4 2017

Jan 16, 2018

BUY
$28.45 - $37.14 $59,745 - $77,994
2,100 Added 7.58%
29,800 $1.02 Million
Q3 2017

Oct 16, 2017

BUY
$24.01 - $36.2 $665,077 - $1 Million
27,700
27,700 $1 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.09B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.